Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by European Institute of Oncology
Information provided by (Responsible Party):
European Institute of Oncology Identifier:
First received: June 15, 2011
Last updated: August 9, 2016
Last verified: August 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2019
  Estimated Primary Completion Date: August 2019 (Final data collection date for primary outcome measure)